Skip to main content

"Being Sober Is Payment Enough." Why a Gift Card Works on Meth Anyway

The one treatment with strong evidence for stimulant addiction pays you to stay clean. It sounds insulting until you understand what stimulants do to the part of your brain that registers reward.

ByThe Rize NewsroomOctober 29, 20266 min readStimulants

A woman in a rewards program in Portland, Maine, was quoted in the New York Times saying something that the program’s designers probably did not put on a poster: “I feel like being sober is payment enough, not waking up sick is payment enough, being trusted is payment enough.” The program rewards negative drug tests, and her verdict on being paid for them was more complicated than gratitude.

Her sentence is the best argument against the treatment and, if you read it twice, the best argument for it.

Paying someone to stay off meth is the best-supported treatment we have for stimulant addiction, and it works because meth broke the part of you that notices ordinary rewards, not because you are greedy.

This is a spotlight on stimulants, meaning methamphetamine, cocaine and the prescription amphetamines. It sits next to today’s reporting on why stimulant deaths are rising, and it is for the person on the receiving end of the word “treatment,” not the one writing it.

What a stimulant does to the way you feel good

Stimulants flood the brain with dopamine, the chemical messenger that tells you “that was worth it, do it again.” That is the plain version of what scientists call the reward system. A normal dinner, a good song or a text from someone you love nudges it a little. Meth and cocaine slam it. Do that often enough and the reward signal dulls, the way your ears stop hearing the loud room after an hour.

The part that matters for recovery is what happens when the drug stops. In a 2012 study in Molecular Psychiatry, researchers used brain scans on people with methamphetamine use disorder in early abstinence and found that lower dopamine activity predicted who went back to using. In a NIDA interview, the clinician Paul Linde described the same pattern from the bedside: many of his patients relapse to escape the long stretch of joylessness, exhaustion and sleeping too much that follows stopping. Clinicians call the flat, joyless part anhedonia. Anyone who has been through it calls it something more direct. Food is cardboard. Music does nothing. Nothing sounds worth getting out of bed for, and the drug is the only thing that ever made it sound worth it.

That is why the usual advice fails. “Just find healthy rewards” assumes the machinery that registers healthy rewards is working. For weeks or months it often isn’t. There is some encouraging news in the same research tradition: a 2001 NIDA-reported imaging study found that dopamine transporters, part of the system that gets damaged, recovered substantially after about nine months of abstinence, though the researchers noted that thinking and function did not recover in step. The brain heals. It heals on its own schedule, and the schedule is slower than anyone’s patience.

Why a voucher can do what a pep talk cannot

Contingency management, the clinical name for the voucher approach, pays small, immediate rewards for evidence of staying off the drug. Evidence usually means a urine test. Rewards escalate with each clean test in a row and reset lower after a positive one. The immediate part is the point. A reward that arrives in a few minutes speaks the reward system’s language. Long-term goods like a repaired relationship or a clean record are real, but they arrive years later, and a brain with dulled reward sensitivity does not hear them.

Think of it as a bridge. The voucher does not replace your reasons. It gives the machinery something to register during the weeks when everything else is silent, and it does so on the schedule the machinery can hear. The evidence for it is the strongest in this field. The ASAM/AAAP clinical guideline on stimulant use disorder recommends it as a primary part of treatment and rates the recommendation strong with high certainty. No medication is FDA-approved for stimulant use disorder; some, such as bupropion, mirtazapine and naltrexone, are used off-label with weaker evidence.

The ASAM/AAAP clinical guideline on stimulant use disorder recommends it as a primary part of treatment and rates the recommendation strong with high certainty.

The reported results are striking, with the caveat that the sources are summaries. The psychiatrists Sally Satel and David Farabee, writing in the Los Angeles Times, describe a Stanford review of 157 cocaine-treatment trials in which contingency management was the standout. They also report that patients in the VA’s program who earned vouchers were 41 percent less likely to die within a year than a matched comparison group. Matched groups are not the same as a randomized trial, and neither the Stanford review nor the VA study is linked in the piece, so hold those numbers the way you would hold any claim you cannot click through to.

Two answers to the same drug

We have watched the country answer cocaine two ways inside five years. In 1986 Congress set mandatory minimums that treated five grams of crack like 500 grams of powder, a gap that stood until 2010. In 1991 the psychologist Stephen Higgins and colleagues published a trial in the American Journal of Psychiatry in which about forty people with cocaine dependence were randomly split into counseling with vouchers for clean urine tests and counseling without, and the voucher group did better. One answer produced decades of sentences. The other produced the best-supported treatment we have for the same family of drugs. The VA began running it at scale in 2011, and as of early 2025 only four state Medicaid programs had approval to pay for it. We knew which tool worked, and we built the other one first.

The insult in it, and why it is worth taking seriously

Go back to the woman in Maine. Her objection is not stupid. People in recovery have spent years being told their motivation is the problem, and now a program hands them a gift card as if the problem were incentive. For someone whose sobriety already costs them a great deal, being paid for it can feel like being priced.

Here is the resolution that holds up. The reward is not payment for your character. It is a tool pointed at a specific, temporary hardware problem, the same way a cast is not an insult to your leg. And her own sentence names the thing the reward is for: not waking up sick, being trusted. Those are the rewards the brain will eventually learn to hear again. The voucher keeps her in the room long enough to hear them.

There is a harder truth underneath. Kastalia Medrano, who used meth daily for years and wrote about it for Filter, argued that the field built its services around opioids and retrofitted them for stimulants. Contingency management is the one tool that was actually designed for this. And access is thin: Satel and Farabee report that, as of early 2025, only four states had Medicaid approval to cover it, and the federal grant ceiling on rewards had just been raised from $75 to $750 per person per year.

If you use stimulants and want to stop, ask any clinic you contact whether they offer contingency management, by name. If you work in a clinic and do not, ask your team this week who in your county is paying for it and whether you can refer to them. If you are using now and cannot talk to anyone about stopping, keep one thing: naloxone still works on mixed overdoses, and fentanyl is turning up in stimulants. Call 988 if you want a person tonight.

The woman in Portland got her gift card and her sentence. Somewhere under both is the thing a stimulant takes first and gives back last: the ability to feel that staying is worth it. The voucher does not give it back. It keeps you in the chair until the ability does.

Somewhere under both is the thing a stimulant takes first and gives back last: the ability to feel that staying is worth it.

Filed Under

psychologytreatmentbiologyMethamphetamineCocaineContingency Management

Keep up with the reporting.

One email each morning with the stories that put days like this in context.

A daily, no-spam briefing. Unsubscribe anytime.

Continue reading

More from this section